viewCollagen Solutions PLC

Collagen Solutions inks distribution deals with two new Chinese partners

The appointment of Dakewe Biotech and Shanghai Regenic Biomedical follows the restructuring of Collagen’s operations in China and the securing of export licences earlier this year

chinese city
The two partners will distribute to different sectors

Collagen Solutions PLC (LON:COS) has signed distribution agreements with two new Chinese channel partners as it looks to grow its presence in what is a “significant territory” for the maker of regenerative medicines.

Under the terms of the deals, Dakewe Biotech and Shanghai Regenic Biomedical will distribute Collagen’s collagen-based products in China, although they will target slightly different markets.

READ: Collagen Solutions looks to have put last year’s difficulties behind it with strong start to current year

Shenzhen-based Dakewe will sell to the research market and engage in business-to-business sales to the medical device industry, while SRB will distribute to the medical device and regenerative medicine sectors.

The appointment of these channel partners follows the restructuring of Collagen’s operations in China and the securing of export licences earlier this year.

The plan is to provide more flexibility in engaging with and providing technical support to Chinese customers, enabling the firm to “take advantage of opportunities” in the country.

“We have made good progress since our restructuring in China and the addition of these two new channel partners is testament to the growth opportunity for us there,” said chief executive Jamal Rushdy.

“We have been working hard to secure these distribution agreements and with these in place, we are now well positioned to engage further with customers in China.

“We look forward to working closely with our new distributors and growing our presence in the region.”

Quick facts: Collagen Solutions PLC

Price: 3.35 GBX

Market: LSE
Market Cap: £14.86 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Collagen Solutions PLC named herein, including the promotion by the Company of Collagen Solutions PLC in any Content on the Site, the Company...



Collagen Solutions reports strong growth in its tissue business in first half

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence update Proactive London's Andrew Scott on first half performance - their third consecutive six-month period of double-digit sales growth. Revenues increased by 14% to £2.23mln in the period ended September 30. Tissue sales more...

6 days, 13 hours ago


Half-year Report

6 days, 14 hours ago

Investor results presentation

2 weeks, 6 days ago

Directorate Change

3 weeks, 5 days ago

Result of AGM

on 28/8/19

AGM Statement

on 28/8/19

2 min read